Notices |
Media Release |
Trading Holidays |
BSEPlus |
BSE SME |
Payments to BSE |
Contact us |
FeedBack
 |
75,157.26
+1310.11 +1.77%
11 Apr 25 | 16:00 | Close
|
Get Quote
BSE RSS
RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. It will show you what's new since the last time you checked the feed, without having to visit the website.
BSE Notices RSS
This RSS feed allows you to stay up to date with the latest Notices updated on the site.
How to Subscribe this feed?
You can subscribe to this feed by using any of the following options:
SENSEX RSS
This is an RSS feed from the Bombay Stock Exchange website. This RSS feeds allow you to stay up to date with the latest SENSEX values on continuous basis.
Subscribe to this feed
To subscribe to it, you will need a RSS Reader. You can subscribe to this RSS feed, Please Cut and Paste the URL www.bseindia.com/data/xml/sensexrss.xml in your RSS Reader
BSE Notices RSS
This RSS feed allows you to stay up to date with the latest Notices updated on the site.
How to Subscribe this feed?
You can subscribe to this feed by using any of the following options:
- If you have RSS reader, Please Cut and Paste the URL www.bseindia.com/data/xml/notices.xml in your RSS Reader.
- Download any online RSS reader of your choice.
SENSEX RSS
This is an RSS feed from the Bombay Stock Exchange website. This RSS feeds allow you to stay up to date with the latest SENSEX values on continuous basis.
Subscribe to this feed
To subscribe to it, you will need a RSS Reader. You can subscribe to this RSS feed, Please Cut and Paste the URL www.bseindia.com/data/xml/sensexrss.xml in your RSS Reader
Industry Classification of SMS Pharmaceuticals Ltd(532815) |
||
| Macro-Economic Indicator | : | Healthcare |
| Sector | : | Healthcare |
| Industry | : | Pharmaceuticals & Biotechnology |
| Basic Industry | : | Pharmaceuticals |
High Lows
| High Lows | ||
| 52 Week High (adjusted) | 398.00 (23/09/2024) | |
| 52 Week Low (adjusted) | 175.00 (07/04/2025) | |
| 52 Week High (Unadjusted) | 398.00 (23/09/2024) | |
| 52 Week Low (Unadjusted) | 175.00 (07/04/2025) | |
| Month H/L | 230.00 / 175.00 | |
| Week H/L | 209.45 / 175.00 | |
Notification
 |
EPS (TTM) Earnings Per Share (Trailing Twelve Months)
Formula = Net Profit attributable to Equity Shareholders (TTM) / No. of Equity Shares
CEPS (TTM) Cash Earnings Per Share (Trailing Twelve Months)
Formula = Net profit attributable to Equity Shareholders (TTM) + Depreciation (TTM) /No. of Equity Shares
PE Price Earnings
Formula = Last Traded Price / EPS(TTM)
PB Price to Book Value
Formula = Last Traded Price / Book Value per Share
Where Book Value per Share = (Total Assets -Total Liabilities)/ No. of Equity Shares outstanding
ROE Return on Equity
Formula = Profit Attributable to Equity Shareholders / Shareholder's Fund
Where Profit Attributable to Equity Shareholders does not include profit attributable to minority shareholders) and
Shareholder's Fund = Equity Share Capital + Other Equity (Does not include Minority Interest)
Note - All the above-mentioned Ratios are based on latest available Standalone Results.
Formula = Net Profit attributable to Equity Shareholders (TTM) / No. of Equity Shares
CEPS (TTM) Cash Earnings Per Share (Trailing Twelve Months)
Formula = Net profit attributable to Equity Shareholders (TTM) + Depreciation (TTM) /No. of Equity Shares
PE Price Earnings
Formula = Last Traded Price / EPS(TTM)
PB Price to Book Value
Formula = Last Traded Price / Book Value per Share
Where Book Value per Share = (Total Assets -Total Liabilities)/ No. of Equity Shares outstanding
ROE Return on Equity
Formula = Profit Attributable to Equity Shareholders / Shareholder's Fund
Where Profit Attributable to Equity Shareholders does not include profit attributable to minority shareholders) and
Shareholder's Fund = Equity Share Capital + Other Equity (Does not include Minority Interest)
Note - All the above-mentioned Ratios are based on latest available Standalone Results.
|
| Previous Close | 198.95 |
| Open | 204.60 |
| High | 205.05 |
| Low | 201.90 |
| VWAP | 204.07 |
| 52 Wk High | 398.00 |
| 52 Wk Low | 175.00 |
| Upper Price Band | 243.90 |
| Lower Price Band | 162.60 |
| Price Band | 20% |
| TTQ | 2921 |
| Turnover (Lakh) | 5.96 |
| 2W Avg Qty`(Lakh) | 0.13 |
| Mcap Full (Cr.) | 1,720.55 |
| Mcap FF (Cr.) | 606.14 |
EPS (TTM)  |
7.18 |
| CEPS (TTM) | 10.97 |
| PE/PB | 28.31 / 3.01 |
| ROE | 10.65 |
| Face Value | 1.00 |
| Category | Listed |
| Group / Settlement Type | B /T+1 |
| Index | BSE SmallCap |
| Basic Industry |
Pharmaceuticals |
Segment :
Announcement Submission Type :
From Date
To Date
Category
Sub Category
Current Page Number 1 out of 1
No of Announcements 43 Till Date 09 Apr 2025
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current Page Number 1 out of 1
DISCLAIMER
| DISCLAIMER |
|
1. The information disseminated seamlessly on the website of BSE Ltd (“Exchange”) in form of Corporate Announcement or in any other form or otherwise is provided “AS IS” and “WITH ALL FAULTS” and without warranty of any kind or nature.
|
|
2. The information uploaded on the Exchange’s website shall be a duty/responsibility/liability of the Company.
|
|
3. The accuracy / adequacy / veracity of any information received from the companies by way of corporate Announcements is NOT pre-verified by the Exchange, before dissemination. The same may be verified by the Exchange only post dissemination on the Exchange website in accordance with the extant rules / guidelines provided by SEBI from time to time.
|
|
4. Exchange shall not be, in any case whatsoever, held in question regarding the accuracy/reliability of the disclosures uploaded by the Company and disseminated on the Exchange website
|
|
5. The Exchange does not warrant, guarantee or make any representations concerning the use, results of use or inability to use the information in terms of timeliness, truthfulness, sequence, completeness, accuracy, reliability, correctness, performance or otherwise regarding/pertaining to the information disseminated in form of Corporate Announcement or in any other form or otherwise on the Website of the Exchange (“Information”).
|
|
6. Exchange does not warrant that the information will be uninterrupted or free of any error, omission, defect, shortcoming or limitation of any kind or nature. The user of the information assumes the entire risk as to the suitability, use, results of use, accuracy, completeness, correctness of the information and shall waive any claim of detrimental reliance upon the information.
|
|
7. Exchange does not warrant that it shall continue to disseminate, transfer or transmit information to the user using the existing facilities or technologies governing/concerning the dissemination of information. Exchange disclaims all responsibility and/or liability for any loss of information, transmission time, revenues, and/ or goodwill which may occur to the User/Company/any other person.
|
|
8. The User/Company/any other person shall, at its own cost and expense, indemnify, defend or at its option settle, and hold BSE free and harmless from and against any and all losses, liabilities, claims, actions, costs and expenses, including reasonable attorneys’ fees and court costs, relating to, resulting from or in any way arising out of any or all information disseminated on the Website of the Exchange.
|
|
9. Any dispute out of or in connection the information shall be subject to the exclusive jurisdiction of the courts of Mumbai, India and shall be governed by Indian law.
|
| Security Code | Company | ||||
| Exchange Disseminated Time | |||||